Registry study for healthy people to collect stomach and esophagus samples
Part of Digestive system clinical trials.
This study enrolls healthy adults to build a registry and biobank (collection of samples). It tests whether collecting information and biological samples from people without symptoms can help researchers understand normal stomach and esophagus function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 85 years old
- Have never had surgery involving the GI (stomach/intestine) tract
- Feel well: no stomach or heartburn-type symptoms on the study questionnaires
- Not take medicines that change stomach acid or gut movement (like acid reducers or certain motility meds)
- Do not smoke, and avoid very heavy or daily alcohol use
- Not be pregnant or nursing
- BMI under 30 and no known hiatus hernia (a stomach-related hernia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
This study will track how well the RefluxStop device works and its safety for treating acid reflux in a general hospital setting. It aims to help people with long-term GERD who have not found relief from other treatments.
This registry study follows people with long-term acid reflux (GERD) who get the RefluxStop treatment. It mainly collects real-world safety and performance information to see how well the device helps over time.
This trial is testing a new way to diagnose gastroesophageal reflux disease (GERD) in people who have symptoms like heartburn, reflux, or bloating. It aims to improve diagnosis so you can get the right treatment.
This trial is a cancer data and blood-sample registry. It collects information from people newly diagnosed with esophagus or stomach (or the stomach–esophagus junction) cancer to help researchers understand treatment patterns and outcomes.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
Hear when a new Gastro Esophageal Reflux trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.